Table 6.6g

Immunosuppression Use for Maintenance Between Discharge

		Year of Transplant
		1998	1999	2000	2001	2002	2003	2004	2005	2006	2007
Transplants		88	139	134	168	181	160	183	199	173	208
Tx with Follow-up Immunosuppression Info		63	109	96	122	141	115	137	148	125	151
Corticosteroids	Any in Category	100.0%	100.0%	96.9%	92.6%	86.5%	56.5%	58.4%	54.7%	59.2%	59.6%
Corticosteroids	Steroids	100.0%	100.0%	96.9%	92.6%	86.5%	56.5%	58.4%	54.7%	59.2%	59.6%
Cyclosporine	Any in Category	19.0%	8.3%	8.3%	5.7%	8.5%	7.0%	3.6%	2.7%	2.4%	4.0%
	Sandimmmune	0.0%	0.0%	2.1%	0.0%	0.0%	0.0%	0.0%	1.4%	0.8%	0.7%
	Neoral	19.0%	8.3%	5.2%	5.7%	6.4%	6.1%	3.6%	1.4%	1.6%	3.3%
	Gengraf	0.0%	0.0%	1.0%	0.0%	1.4%	0.9%	0.0%	0.0%	0.0%	0.0%
	Eon	0.0%	0.0%	0.0%	0.0%	0.7%	0.0%	0.0%	0.0%	0.0%	0.0%
Tacrolimus	Any in Category	96.8%	96.3%	95.8%	98.4%	95.0%	84.3%	85.4%	97.3%	97.6%	95.4%
Tacrolimus	Tacrolimus	96.8%	96.3%	95.8%	98.4%	95.0%	84.3%	85.4%	97.3%	97.6%	95.4%
Antimetabolites	Any in Category	93.7%	93.6%	81.3%	73.8%	63.8%	60.0%	60.6%	64.2%	60.8%	62.9%
	Mycophenolate Mofetil	81.0%	91.7%	76.0%	70.5%	63.8%	59.1%	54.7%	56.1%	52.8%	52.3%
	Mycophenolate Sodium	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	4.7%	6.4%	6.6%
	Azathioprine	12.7%	1.8%	5.2%	3.3%	0.0%	0.9%	5.8%	3.4%	1.6%	4.0%
mTOR Inhibitors	Any in Category	0.0%	17.4%	27.1%	16.4%	33.3%	24.3%	26.3%	27.7%	28.8%	23.8%
	Sirolimus	0.0%	17.4%	27.1%	16.4%	33.3%	24.3%	26.3%	27.7%	28.8%	23.8%
	Everolimus	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%